David Martín‐Oliva
- Molecular Biology top 10%
- Oncology top 5%
- Neurology top 2%
- Immunology top 10%
- Ophthalmology top 2%
- Co-authors
- Miguel A. CuadrosF. Javier OliverJosé L. Marín‐TevaJulio NavascuésJosé Antonio Muñoz‐GámezRocío Aguilar‐QuesadaR. QuilesRuth Calvente
- Topics
- PARP inhibition in cancer therapy (20 papers)Neuroinflammation and Neurodegeneration Mechanisms (13 papers)Cell death mechanisms and regulation (10 papers)
- Cited by
- NeurologyOphthalmologyOncology
- Journals
- PLoS ONEHepatologyCancer Research
- Partner nations
- SpainUnited KingdomFrance
In The Last Decade
David Martín‐Oliva
41 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 844
- Oncology 576
- Neurology 369
- Immunology 242
- Ophthalmology 224
Countries citing papers authored by David Martín‐Oliva
This map shows the geographic impact of David Martín‐Oliva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Martín‐Oliva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Martín‐Oliva more than expected).
Fields of papers citing papers by David Martín‐Oliva
This network shows the impact of papers produced by David Martín‐Oliva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Martín‐Oliva. The network helps show where David Martín‐Oliva may publish in the future.
Co-authorship network of co-authors of David Martín‐Oliva
This figure shows the co-authorship network connecting the top 25 collaborators of David Martín‐Oliva. A scholar is included among the top collaborators of David Martín‐Oliva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Martín‐Oliva. David Martín‐Oliva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 13 | |
| 8 | 24 | |
| 9 | 9 | |
| 10 | 68 | |
| 11 | 18 | |
| 12 | 8 | |
| 13 | 109 | |
| 14 | 14 | |
| 15 | 48 | |
| 16 | 138 | |
| 17 | 117 | |
| 18 | 5 | |
| 19 | 7 | |
| 20 | 50 |
About David Martín‐Oliva
David Martín‐Oliva is a scholar working on Neurology, Oncology and Transplantation, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (20 papers), Neuroinflammation and Neurodegeneration Mechanisms (13 papers) and Cell death mechanisms and regulation (10 papers). The work is most often cited by research in Neurology (369 citations), Ophthalmology (224 citations) and Oncology (576 citations). David Martín‐Oliva has collaborated with scholars based in Spain, United Kingdom and France. Frequent co-authors include Miguel A. Cuadros, F. Javier Oliver, José L. Marín‐Teva, Julio Navascués, José Antonio Muñoz‐Gámez, Rocío Aguilar‐Quesada, R. Quiles, Ruth Calvente, Maria‐Carmen Carrasco and Mariano Ruiz de Almodóvar. Their work appears in journals such as PLoS ONE, Hepatology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.